JDD wrote: » I stood in front of a rack of masks on Friday, considering should I buy another couple for myself and the kids. Then I thought, f*ck it, it'll only be another few months until we get roll out of the vaccine. We can put up with the stock of masks we have right now. Then I went off and bought a dress that's essentially for the office. I'm already winding down this whole pandemic thing in my head.
tobefrank321 wrote: » Amazing to think 70% efficacy is considered disappointing, and I include myself in that bracket. You'd wonder who will take up the Oxford vaccine now. Obviously the higher the efficacy the more normality can return. Leaving 30% at risk without knowing which 30% is at risk is the problem. Hopefully more data will follow. If it turns out the 30% not protected are elderly or with poor immune systems, then the other vaccines should cover them.
ACitizenErased wrote: » The media have latched onto the 70% big time
stephenjmcd wrote: » Well its not 70% its 90% on a different dosing regime. 70 is just the average between both doses. As for who will take it, chances are your not going to know which one your getting, to be honest why should you ? Not something that you can pick and chose oh I don't want that vaccine I want this one. It'll be a clinical decision
Russman wrote: » If you're getting it it your GPs you'll know its likely not the Pfizer one though, no ? Actually, as an aside, would the government be tracking which vaccine everyone who took one got ? To help with further evaluations on each candidate, like a massive extension of Phase 3 ? Its ok, GDPR heads, don't lose your sh1t because someone asked the question !
ACitizenErased wrote: » You’ll know which one you get because you get the HPRA leaflet after every vaccination
plodder wrote: » Would they not have to repeat the whole phase 3 again with this dosage?
Hmmzis wrote: » Nope, they'll just keep going with the current one and get some lab results back to confirm one way or another of why the mixed doses appear to do better.
opinionated3 wrote: » Ftse100 is up since the announcement but why would astrazeneca drop by 1.5%.....??
stephenjmcd wrote: » Because its not being seen as great news for some reason as the headline is 70% efficacious, despite 90% being seen. Markets comparing v moderna and Pfizer announcements. Alot to do with how certain media elements are reporting it.
stephenjmcd wrote: » Because its not being seen as great news for some reason as the headline is 70% efficacious, despite 90% being seen. Markets comparing v moderna and Pfizer announcements.
hmmm wrote: » Plus I think the mRNA platforms have blown everyone else out of the water and to the interested observer (which financial markets are) they look like the future. Oxford may be in an unfortunate situation where brilliant science has been surpassed by even more brilliant science.
dominatinMC wrote: » I just don't get it. Why the endless obsession with misery
Thierry12 wrote: » If you look at the data it could be the opposite? Pfzier and Moderna didn't include asymptomatic as an infection Oxford did it seems Oxford has 0 severe sick and 0 moderately sick I believe ( no hospital ) Other 2 did This percentage thing is very misleading until all data is out It doesn't look like for like to me
ixoy wrote: » At least the Independent's headline is actually reporting what the data appears to say: "Oxford University vaccine shows up to 90 pc effective against Covid-19, data suggests"
Stark wrote: » Interesting that of the two dosing regimes, the half dose followed by full dose performed better than two full doses.